Xylem Inc. $XYL Shares Sold by Deutsche Bank AG

Deutsche Bank AG lowered its position in Xylem Inc. (NYSE:XYL) by 14.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,007,141 shares of the industrial products company’s stock after selling 350,835 shares during the quarter. Deutsche Bank AG’s holdings in Xylem were worth $273,332,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in the company. Fisher Asset Management LLC boosted its holdings in Xylem by 6.4% during the third quarter. Fisher Asset Management LLC now owns 404,613 shares of the industrial products company’s stock worth $59,681,000 after buying an additional 24,352 shares in the last quarter. LGT Capital Partners LTD. boosted its holdings in Xylem by 18.4% during the third quarter. LGT Capital Partners LTD. now owns 268,704 shares of the industrial products company’s stock worth $39,634,000 after buying an additional 41,730 shares in the last quarter. Northwestern Mutual Wealth Management Co. boosted its holdings in Xylem by 2,309.7% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 431,824 shares of the industrial products company’s stock worth $54,314,000 after buying an additional 413,904 shares in the last quarter. Boston Common Asset Management LLC boosted its holdings in Xylem by 15.3% during the fourth quarter. Boston Common Asset Management LLC now owns 143,740 shares of the industrial products company’s stock worth $19,575,000 after buying an additional 19,073 shares in the last quarter. Finally, Abacus Wealth Partners LLC bought a new stake in Xylem during the fourth quarter worth approximately $1,663,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

Analyst Upgrades and Downgrades

XYL has been the subject of a number of research reports. Weiss Ratings cut shares of Xylem from a “hold (c+)” rating to a “hold (c)” rating in a report on Friday, May 8th. TD Cowen reissued a “hold” rating on shares of Xylem in a research note on Monday, February 23rd. The Goldman Sachs Group set a $158.00 target price on shares of Xylem in a research note on Wednesday, February 11th. Oppenheimer cut their target price on shares of Xylem from $160.00 to $158.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 29th. Finally, Royal Bank Of Canada cut their target price on shares of Xylem from $176.00 to $162.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 11th. Seven equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat, Xylem currently has an average rating of “Moderate Buy” and an average price target of $152.77.

Insider Activity

In other Xylem news, Director Jerome A. Peribere bought 1,210 shares of the firm’s stock in a transaction dated Monday, May 4th. The shares were acquired at an average cost of $116.61 per share, for a total transaction of $141,098.10. Following the transaction, the director owned 27,209 shares in the company, valued at approximately $3,172,841.49. The trade was a 4.65% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CAO Geri-Michelle Mcshane sold 4,269 shares of Xylem stock in a transaction dated Thursday, May 7th. The shares were sold at an average price of $117.46, for a total transaction of $501,436.74. Following the sale, the chief accounting officer owned 3,605 shares in the company, valued at approximately $423,443.30. This trade represents a 54.22% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 0.32% of the company’s stock.

Xylem Stock Performance

Shares of XYL opened at $107.34 on Thursday. The company has a market capitalization of $25.51 billion, a PE ratio of 26.70, a price-to-earnings-growth ratio of 1.58 and a beta of 1.04. Xylem Inc. has a one year low of $105.29 and a one year high of $154.27. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.46 and a quick ratio of 1.10. The company’s fifty day moving average price is $116.24 and its 200 day moving average price is $127.70.

Xylem (NYSE:XYL) last posted its quarterly earnings data on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.09 by $0.03. Xylem had a net margin of 10.79% and a return on equity of 11.26%. The company had revenue of $2.13 billion for the quarter, compared to the consensus estimate of $2.11 billion. During the same quarter in the previous year, the firm posted $1.03 EPS. The business’s revenue was up 2.7% compared to the same quarter last year. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. As a group, analysts expect that Xylem Inc. will post 5.51 earnings per share for the current year.

Xylem Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 25th. Stockholders of record on Thursday, May 28th will be issued a dividend of $0.43 per share. The ex-dividend date is Thursday, May 28th. This represents a $1.72 annualized dividend and a dividend yield of 1.6%. Xylem’s payout ratio is presently 42.79%.

Xylem declared that its board has approved a share buyback plan on Wednesday, February 25th that permits the company to repurchase $1.50 billion in outstanding shares. This repurchase authorization permits the industrial products company to purchase up to 4.8% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company’s leadership believes its shares are undervalued.

Xylem Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.